These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 31657022)

  • 1. Managing conflicts of interest in pharmacy and therapeutics committees: A proposal for multicentre formulary development.
    Friesen P; Caplan AL; Miller JE
    J Clin Pharm Ther; 2020 Apr; 45(2):249-255. PubMed ID: 31657022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Literature review on the structure and operation of Pharmacy and Therapeutics Committees.
    Durán-García E; Santos-Ramos B; Puigventos-Latorre F; Ortega A
    Int J Clin Pharm; 2011 Jun; 33(3):475-83. PubMed ID: 21416393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving the presentation of drug information to pharmacy and therapeutics committees for formulary decisions.
    Sterné SC; Uchida KM; Iteen SA
    Am J Health Syst Pharm; 1996 May; 53(10):1162-4. PubMed ID: 8734677
    [No Abstract]   [Full Text] [Related]  

  • 4. Formulary systems and pharmacy and therapeutics committees in the Western Pacific Region: exploring two Basel Statements.
    Penm J; Chaar B; Dechun J; Moles R
    Am J Health Syst Pharm; 2013 Jun; 70(11):967-79. PubMed ID: 23686603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activities, functions, and structure of pharmacy and therapeutics committees in large teaching hospitals.
    Mannebach MA; Ascione FJ; Gaither CA; Bagozzi RP; Cohen IA; Ryan ML
    Am J Health Syst Pharm; 1999 Apr; 56(7):622-8. PubMed ID: 10423208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies for success in creating an effective multihospital health-system pharmacy and therapeutics committee.
    Leonard MC; Thyagarajan R; Wilson AJ; Sekeres MA
    Am J Health Syst Pharm; 2018 Apr; 75(7):451-455. PubMed ID: 29572313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contemporary challenges and novel strategies for health-system formulary management.
    Heindel GA; McIntyre CM
    Am J Health Syst Pharm; 2018 Apr; 75(8):556-560. PubMed ID: 29626005
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug formulary decision-making: Ethnographic study of 3 pharmacy and therapeutics committees.
    Schiff GD; Tripathi JB; Galanter W; Paek JL; Pontikes P; Fanikos J; Matta L; Lambert BL
    Am J Health Syst Pharm; 2019 Apr; 76(8):537-542. PubMed ID: 30915453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hashing out a policy on conflicts of interest for a P&T committee.
    Fredrick DS; Maddock JR; Graman PS
    Am J Health Syst Pharm; 1995 Dec; 52(24):2791-2. PubMed ID: 8748564
    [No Abstract]   [Full Text] [Related]  

  • 10. Improving pharmacy and therapeutics committee operations.
    Cohen MR; Klapp D; Miller KB; Shaffer VL; Slotfeldt M; Miller DE
    Am J Hosp Pharm; 1984 Sep; 41(9):1767-77. PubMed ID: 6496511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and activities of pharmacy and therapeutics committees among public hospitals in South Africa; findings and implications.
    Matlala M; Gous AG; Godman B; Meyer JC
    Expert Rev Clin Pharmacol; 2017 Nov; 10(11):1273-1280. PubMed ID: 28776442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ASHP national survey of pharmacy practice in hospital settings: prescribing and transcribing--2004.
    Pedersen CA; Schneider PJ; Scheckelhoff DJ
    Am J Health Syst Pharm; 2005 Feb; 62(4):378-90. PubMed ID: 15745890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formularies: the role of pharmacy-and-therapeutics (P&T) committees.
    Summers KH; Szeinbach SL
    Clin Ther; 1993; 15(2):433-41; discussion 432. PubMed ID: 8519049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The formulary decision-making process in a US academic medical centre.
    Nash DB; Catalano ML; Wordell CJ
    Pharmacoeconomics; 1993 Jan; 3(1):22-35. PubMed ID: 10146985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A survey of selective administration procedures in formulary maintenance.
    Quigley MA; Brown WM
    Hosp Pharm; 1981 Jul; 15(7):371-4, 378-80. PubMed ID: 10252001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ASHP national survey of pharmacy practice in hospital settings: prescribing and transcribing--2001.
    Pedersen CA; Schneider PJ; Santell JP
    Am J Health Syst Pharm; 2001 Dec; 58(23):2251-66. PubMed ID: 11763804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementing and maintaining a viable formulary.
    Kelly WN; Bender FH
    Hosp Formul; 1983 Oct; 18(10):976-8, 981-2, 987. PubMed ID: 10262828
    [No Abstract]   [Full Text] [Related]  

  • 18. How to use structured decision making in developing therapeutic, cost-effective formulary systems.
    Crane VS
    Hosp Formul; 1993 Oct; 28(10):859-62, 865-7. PubMed ID: 10129135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practical approach to grading evidence for formulary recommendations.
    Ansani NT; Fedutes-Henderson BA; Skledar SJ; Branch R; Sirio CA; Smitherman T; Weber RJ
    Am J Health Syst Pharm; 2005 Jul; 62(14):1498-501. PubMed ID: 15998932
    [No Abstract]   [Full Text] [Related]  

  • 20. Managing potential conflicts of interest in state Medicaid pharmacy and therapeutics committees: seeking harmony.
    Shah N
    JAMA Intern Med; 2013 Mar; 173(5):344. PubMed ID: 23400627
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.